5-Fluoro derivatives of 4-epi-isofagomine as D-galactosidase inhibitors and potential pharmacological chaperones for GM1-gangliosidosis as well as Fabry's disease

Martin Thonhofer, Andres Gonzalez Santana, Roland Fischer, Ana Torvisco Gomez, Robert Saf, Michael Schalli, Arnold Stütz, Stephen G. Withers

Publikation: Beitrag in einer Fachzeitschrift › Artikel › Begutachtung

Fingerprint

Untersuchen Sie die Forschungsthemen von „5-Fluoro derivatives of 4-epi-isofagomine as D-galactosidase inhibitors and potential pharmacological chaperones for GM1-gangliosidosis as well as Fabry's disease“. Zusammen bilden sie einen einzigartigen Fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science